Kairos Pharma engages Barretto Pacific Corporation for investor relations services.

Kairos Pharma has engaged Barretto Pacific Corporation to provide services including disseminating public information about the company's business and affairs in the US to investment professionals and private parties. The services will be in consideration of the company's payment of the agreed fee. The agreement is effective from June 10, 2025.

Title: Kairos Pharma Engages Barretto Pacific for US Public Information Dissemination

Kairos Pharma has recently announced that it has entered into an agreement with Barretto Pacific Corporation to provide services related to disseminating public information about the company's business and affairs in the US to investment professionals and private parties. The services will commence on June 10, 2025, and will be in consideration of the company's payment of the agreed fee.

This move by Kairos Pharma aims to enhance transparency and communication with stakeholders, a critical aspect for any publicly traded company. The engagement with Barretto Pacific, a well-known firm in the industry, suggests that Kairos Pharma is committed to maintaining high standards of corporate governance and investor relations.

The agreement is effective from June 10, 2025, and the services will be provided in line with the company's payment schedule. This strategic partnership underscores Kairos Pharma's dedication to ensuring that its operations and financial health are communicated effectively to a wide range of audiences.

References

[1] https://www.benzinga.com/analyst-stock-ratings/analyst/591c741c290fa70001b157cb/jason-kolbert